San Diego Biotechs Seek to Go Public As Market Warms, Amid Two Year Slowdown

San Diego Lawyer and Banker Share What They're Seeing in the IPO Market in 2024

This is a subscriber-only edition of our premium newsletter designed to make you a better investor and executive. Members get access to funding scoops, stealth companies, and wisdom of exceptional investors and founders.

---

San Diego’s Rapport Therapeutics closed $154 million after going public in June. The IPO shows that the U.S. IPO market has made a strong comeback after two dismal years.

---

In 2024, the IPO market has seen more companies go public than the year prior.
Senior lawyers and investment bankers said the IPO activity in San Diego and nationwide is up from last year.